ROS, E.O. 2021. The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited. Reactive Oxygen Species. 11, (Feb. 2021), n7–n8. DOI:https://doi.org/10.20455/ros.2021.n.807.